Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction

NCT05984134 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myocardial Infarction

Interventions

DRUG: NL005 Middle Dose
DRUG: NL005 High Dose
DRUG: Placebo

Sponsor

Beijing Northland Biotech. Co., Ltd.